Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
Introduction: Treatment failure and disease progression (PD) in neuroendocrine tumours (NETs), a rare group of malignancies, are common due to limited targeted treatments.
Conference:
Presenting Author:
Authors: Karim E, Sola-Morales O, Bensegnor H, Chan K, Drane E,
Keywords: Neuroendocrine Tumour, Systematic Literature Review, Economic,
Introduction: Neuroendocrine neoplasms (NENs) are associated with poor health-related quality of life (HRQOL) due to tumor and hormonal related symptoms and treatment-related toxicity. Peptide receptor radionuclide therapy (PRRT) delivers targeted therapy for tumor and hormonal control.
Conference:
Presenting Author: Cehic G
Authors: Cehic G, Kong G, Corsini N, Chan D, Pavlakis N,
Introduction: Pancreatic neuroendocrine neoplasms (pNENs), have often a good prognosis in terms of survival.
Conference:
Presenting Author: Milanetto A
Authors: Milanetto A, Armellin C, Pasquali C,
Keywords: enucleation, pancreatic, NET, quality of life,
#3552 Fatigue and quality of life in patients with neuroendocrine neoplasia
Introduction: Neuroendocrine Neoplasms (NEN) are rare tumors and health related quality of life (HRQoL) may be modulated by the disease and the accompanying carcinoid syndrome seen especially in small intestinal NENs. Further, cancer related fatigue is one of the most common side effects of cancer and its treatments and may persist for years after treatment completion.
Conference:
Presenting Author: Hummelshøj N
Authors: Hummelshøj N, Grønbæk H, Bager P, Tabaksblat E, Dam G,
Keywords: Neuroendocrine, HRQoL, Fatigue, Patient reported outcome, Carcinoid syndrome,
Introduction: Neuroendocrine neoplasms (NENs) affect health-related quality of life (HRQOL) due to tumor burden, hormone-secretory symptoms, and treatment-related side effects.
Conference:
Presenting Author: Kong G
Authors: Kong G, Corsini N, Hogg A, Mercurio J, Bailey D,
Keywords: PRRT, HRQOL, Neuroendocrine neoplasm, Multi-centre study, QLQ-C30,